May 26, 2005 — The U.S. Food and Drug Administration has approved an extended-release tablet formulation of ciprofloxacin HCl with a favorable adverse event profile for the treatment of uncomplicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results